Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Hu, H
Title
Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.
Citation
Cancer cell; 2021 Nov 8; 39(11) pg1531-1547.e10
PubMed ID
34624218
Show Usages
Product Cited
Cross-Reactivity
Applications
100-39
Human
in vitro
100-17A
Human
in vitro
100-18B
Human
in vitro
100-34
Human
in vitro
100-19
Human
in vitro
100-23
Human
in vitro
100-21
Human
in vitro
First Author
Meseguer-Ripolles, J
Title
Protocol for automated production of human stem cell derived liver spheres.
Citation
STAR protocols; 2021 Jun 18; 2(2) pg100502
PubMed ID
33997816
Show Usages
Product Cited
Cross-Reactivity
Applications
100-39
Human
in vitro
100-18B
Human
in vitro
AF-100-15
Human
in vitro
100-17A
Human
in vitro
160-05
Human
in vitro
300-10
Human
in vitro
First Author
Huang, L
Title
Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids.
Citation
Cell stem cell; 2021 Jun 3; 28(6) pg1090-1104.e6
PubMed ID
33915081
Show Usages
Product Cited
Cross-Reactivity
Applications
100-21
Human
in vitro
100-26
Human
in vitro
100-18C
Human
in vitro
AF-100-15
Human
in vitro
120-17
Human
in vitro
100-17A
Human
in vitro
First Author
Futrega, K
Title
A single day of TGF-β1 exposure activates chondrogenic and hypertrophic differentiation pathways in bone marrow-derived stromal cells.
Citation
Communications biology; 2021 Jan 4; 4(1) pg29
PubMed ID
33398032
Show Usages
Product Cited
Cross-Reactivity
Applications
100-17A
Human
in vitro
100-21
Human
in vitro
First Author
Wang, C
Title
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2
Citation
Nature communications; 2020 Jun 22; 11(1) pg3162
PubMed ID
32572027
Show Usages
Product Cited
Cross-Reactivity
Applications
100-17A
Human
in vitro
First Author
Kusakabe, M
Title
Synthetic modeling reveals HOXB genes are critical for the initiation and maintenance of human leukemia.
Citation
Nature Communications;2019 7 2; 10(1) pg2913
PubMed ID
31266935
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-19
Human
in vitro
300-18
Human
in vitro
100-12
Human
in vitro
100-17A
Human
in vitro
200-07
Human
in vitro
217-17
Mouse
in vivo
First Author
Xu, Y
Title
Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling.
Citation
Journal of Cellular and Molecular Medicine; 2018 Nov; 22(11) pg5596-5606
PubMed ID
30160357
Show Usages
Product Cited
Cross-Reactivity
Applications
100-17A
Human
in vitro
First Author
Melguizo-Sanchis, D
Title
iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.
Citation
Cell death & disease; 2018 Jan 26; 9(2) pg128
PubMed ID
29374141
Show Usages
Product Cited
Cross-Reactivity
Applications
100-20
Human
in vitro
120-14E
Human
in vitro
100-17A
Human
in vitro
300-07
Human
in vitro
100-12
Human
in vitro
300-18
Human
in vitro
First Author
Xiao, Z
Title
A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia.
Citation
Science Signaling; 2016 Nov 22; 9(455) pgra113
PubMed ID
27879395
Show Usages
Product Cited
Cross-Reactivity
Applications
100-17A
Human
in vitro
100-31
Human
in vitro
100-34
Human
in vitro
100-23
Human
in vitro
100-28
Human
in vitro
100-32
Human
in vitro
100-41
Human
in vitro
First Author
Vanhove, J
Title
H3K27me3 Does Not Orchestrate the Expression of Lineage-Specific Markers in hESC-Derived Hepatocytes In Vitro.
Citation
Stem Cell Reports; 2016 Aug 9; 7(2) pg192-206
PubMed ID
27477635
Show Usages
Product Cited
Cross-Reactivity
Applications
120-14E
Human
in vitro
120-05ET
Human
in vitro
315-20
Human
in vitro
100-39
Human
in vitro
100-17A
Human
in vitro
showing 10 of 34
Show More